Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.

ProPharma is a global research consulting company and a Dual-Category Award Winner in the 2024 Clinical Trials Arena Excellence Awards. ProPharma, a global research consulting company headquartered in ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

The PALIZADE trial aims to assess the efficacy and safety of zetomipzomib in active lupus nephritis patients. Credit: Sebastian Kaulitzki / Shutterstock. US-based biopharmaceutical company Kezar Life ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.

The trial enrolled chronic myeloid leukaemia patients irrespective of their T315I mutation status. Credit: Nemes Laszlo/Shutterstock. Enliven Therapeutics has reported the latest positive results from ...

This week on Pipeline Moves, we kick off by looking at Pfizer’s topline data from a Phase II trial of ponsegromab on cancer cachexia. Meanwhile, IMPACT Therapeutics senaparib has seen its phase ...

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...